Related Experiment Video
Updated: Jun 27, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Association of the TRIM family protein with survival outcomes and clinicopathological features in colorectal cancer:
Ying Wu1, Chen Chen1, Xian Hua1
1Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, China.
Elevated Tripartite Motif (TRIM) proteins correlate with shorter survival and advanced stages in colorectal cancer (CRC). These findings suggest TRIM proteins are potential therapeutic targets for CRC patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Tripartite Motif (TRIM) proteins are implicated in various cancers.
- The prognostic value of TRIM proteins in colorectal cancer (CRC) is debated.
- This study clarifies the association between TRIM proteins and CRC patient outcomes.
Purpose of the Study:
- To determine if TRIM proteins serve as prognostic factors in colorectal cancer (CRC).
- To evaluate the relationship between TRIM protein expression and clinicopathological features in CRC patients.
Main Methods:
- A meta-analysis was conducted on studies from multiple databases (PubMed, Embase, Web of Science, CNKI, Weipu).
- Eligible studies evaluated TRIM proteins' association with overall survival (OS) and clinicopathological features in CRC.
- Fixed-effects models were used to pool hazard ratios (HR) and odds ratios (OR) with 95% confidence intervals (CI).
Main Results:
- Twelve studies including 1608 patients were analyzed.
- Elevated TRIM proteins significantly correlated with shorter OS (HR=2.42) and worse recurrence-free survival (RFS) (HR=2.51).
- TRIM overexpression was linked to advanced TNM stage, deep invasion, lymph node metastasis, and perineural invasion.
Conclusions:
- TRIM proteins are significant predictors of tumor progression and poor prognosis in CRC.
- TRIM proteins represent potential therapeutic targets for colorectal cancer treatment.
More Related Videos
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Survival Analysis
Truncation in Survival Analysis
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...

